Marinus Pharmaceuticals
MRNS
#10575
Rank
NZ$55.16 M
Marketcap
NZ$1.00
Share price
0.00%
Change (1 day)
-61.28%
Change (1 year)

Earnings for Marinus Pharmaceuticals (MRNS)

Earnings in 2024 (TTM): -NZ$0.23 Billion

According to Marinus Pharmaceuticals's latest financial reports the company's current earnings are NZ$31.46 Million. In 2023 the company made an earning of -NZ$0.26 Billion a decrease over its 2022 earnings that were of -NZ$29.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Marinus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.23 Billion-12.36%
2023 -NZ$0.26 Billion770.17%
2022 -NZ$29.84 Million-83.37%
2021 -NZ$0.18 Billion46.39%
2020 -NZ$0.13 Billion24.67%
2019 -NZ$98.31 Million47.37%
2018 -NZ$66.71 Million94.33%
2017 -NZ$34.33 Million-34.02%
2016 -NZ$52.03 Million15.24%
2015 -NZ$45.15 Million129.47%
2014 -NZ$19.68 Million105.55%
2013 -NZ$9.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Supernus Pharmaceuticals
SUPN
-NZ$65.74 Million-74.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-NZ$4.35 Billion 1,602.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AcelRx Pharmaceuticals
ACRX
-NZ$18.69 Million-92.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
NZ$64.77 M-125.38%๐Ÿ‡บ๐Ÿ‡ธ USA